SIREN : 802642066
SEBAG 26 is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75019), this company of category PME shows in 2017 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | 1 165 856 € | 1 162 030 € |
| Net income | 29 262 € | -42 403 € | 50 551 € | 39 814 € | 3 595 € | -2 954 € | -24 131 € | 28 188 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | N/C | -24 848 € | 31 107 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | -2.1% | 2.4% |
In 2023, SEBAG 26 generates positive net income of 29 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 28 k€ -> 29 k€.
29 262 €
The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
2.903%
92.577%
85.6%
In 2023, the debt ratio of SEBAG 26 (2.90) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2023, the financial autonomy of SEBAG 26 (92.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 2078.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
2078.396
In 2023, the liquidity ratio of SEBAG 26 (2078.40) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 220 transactions of similar company sales in 2023, the value of SEBAG 26 is estimated at 345 276 € (range 209 979€ - 485 380€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SEBAG 26 with other companies in the same sector:
The revenue of SEBAG 26 in 2017 is 1.2 M€.
Yes, SEBAG 26 generated a net profit of 29 k€ in 2023.
The headquarters of SEBAG 26 is located in PARIS (75019), in the department Paris.
The tax return of SEBAG 26 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SEBAG 26 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.